Molecular epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from a medical intensive care unit: A comparison of nasal and clinical isolates

American Journal of the Medical Sciences

Volumn 345, Issue 5, 2013, Pages 361-365

  Luo, Limei ^a   Xie, Yi ^a   He, Chao ^a   Qiao, Fu ^a   Zhuang, Hongdi ^a   Guo, Liang ^a   Yin, Weijia ^a   Kang, Mei ^a   Wang, Lanlan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Infection control; Methicillin resistant Staphylococcus aureus; MRSA select agar; Rep PCR

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; COMPARATIVE STUDY; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; MOLECULAR PHYLOGENY; NOSE SMEAR; PROSPECTIVE STUDY; SURGICAL SWAB;

EID: 84876867035     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31825b5443     Document Type: Article

References (14)

1. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44.
2. Coia JE, Duckworth GJ, Edwards DI, et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006;63(suppl 1): S1-44.
3. Millar BC, Xu J, Moore JE. Molecular diagnostics of medically important bacterial infections. Curr Issues Mol Biol 2007;9:21-39.
4. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-20.
5. Harbarth S, Hawkey PM, Tenover F, et al. Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents 2011;37:110-7.
6. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: Molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002;2:180-9.
7. Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002;99:7687-92.
8. Shutt CK, Pounder JI, Page SR, et al. Clinical evaluation of the DiversiLab microbial typing system using repetitive-sequence-based PCR for characterization of Staphylococcus aureus strains. J Clin Microbiol 2005;43:1187-92.
9. Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing, M100-S16, 16th ed. Wayne, PA: CLSI; 2006.
10. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med 2006;119:S20-8; discussion S62-70.
11. Giannouli M, Cuccurullo S, Crivaro V, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol 2010;48:1223-30.
12. Oztoprak N, Cevik MA, Akinci E, et al. Risk factors for ICU-acquired methicillin-resistant Staphylococcus aureus infections. Am J Infect Control 2006;34:1-5.
13. Harbarth S, Masuet-Aumatell C, Schrenzel J, et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: An interventional cohort study. Crit Care 2006;10:R25.
14. Cunningham R, Jenks P, Northwood J, et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 2007;65:24-8.